U.S. market Closed. Opens in 1 hour 40 minutes

BSX | Boston Scientific Corporation Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for BSX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is very poor, Growth is very good and Health is passable.

Valuation (21%)

Company Industry
P/E Ratio (TTM) 69.61 48.02
PEG Ratio (TTM) -43.16 -0.83
P/S Ratio (TTM) 7.83 6.15
P/B Ratio (TTM) 6.11 6.12
P/FCF Ratio (TTM) 70.79 42.36
Price to 5YR AVG Earnings Ratio 75.57 60.05
Price to 5YR AVG FCF Ratio 96.68 34.49

Profitability (40%)

Company Industry
ROA (TTM) 4.82% 5.35%
ROE (TTM) 9.12% 28.08%
Net Profit Margin (TTM) 11.25% 7.83%
ROIC 5YR AVG 6.88% 6.72%

Growth (80%)

4QTR AVG 3YR AVG 5YR AVG
EPS 2.54% 291.60% 196.00%
Revenue 4.53% 7.18% 8.10%
Net Income 1.98% 307.29% 203.43%
Cash Flow 89.01% 166.13% 108.81%

Health (54%)

Company Industry
Current Ratio (TTM) 1.61 2.87
Quick Ratio (TTM) 1.14 2.15
D/E Ratio (TTM) 0.52 0.62
Interest Coverage (TTM) 9.46 22.95
Piotroski F-Score 7 6
Altman Z-Score 5.35 7.63
LTL to 5YR AVG FCF 6.96 3.49
Shares Outstanding Growth 5YR AVG 1.02% 1.63%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙